Jornal Vascular Brasileiro
https://jvascbras.org/article/doi/10.1590/S1677-54492011000200007
Jornal Vascular Brasileiro
Artigo Original

Association of lipids with coronary heart disease in a saudi population

Associação de lípidos com doença cardíaca coronariana em população saudita

Mohmed Elfatih Ashmaig; Khalifa Ashmeik; Atif Ahmed; Samia Sobki; Muheeb Abdulla

http://dx.doi.org/10.1590/S1677-54492011000200007 J Vasc Bras, vol.10, n2, p.131-136, 2011
PDF
SciELO
Downloads: 0
Views: 1092

Abstract

BACKGROUND: The Saudi population is known to have an unhealthy diet in addition to physical inactivity. OBJECTIVE: To investigate the lipid-mediated risk factors that might be associated with increased incidence of coronary heart diseasein the Saudi population as this was found in Western populations. MATERIALS AND METHODS: Two hundred and twenty subjects suspected of having coronary heart disease underwent coronary angiography and blood draw following a 12-hour fast. Total and HDL cholesterol, triglycerides, Lp(a) and lipoprotein lipase were measured by standard methods. Small, dense LDL was measured by the iodixanol method with an ultracentrifugation of only 2.5 hours. RESULTS: One hundred and forty subjects were found to be positive for coronary heart disease while 80 subjects were shown to be negative for this disease. Statistically significant risk factors for coronary heart disease in the Saudi population were hypertriglyceridemia (1.93±0.95 versus1.45±0.16 mmol/L;p<0.0001); low HDL cholesterol (1.09±0.55 vs 1.33±0.63 mmol/L, p=0.0001); high Lp(a) (46.8±45.58 versus 29.06±17.03 mg/dL;p=0.019); and the presence of small, dense LDL (1.0314±0.0028 versus 1.0300±0.0003 g/kg;p=0.0099). Total cholesterol (4.99±1.11 versus 4.75±1.11 mmol/L;p=0.099), LPL (35.56±26.6 versus 27.89±11.96 IU/L;p<0.059), and LDL cholesterol (3.06±1.12 versus 2.79±1.08 mmol/L;p=0.08) were not found to be statistically significant coronary heart disease risk factors. CONCLUSIONS: This study indicates that high TG, low HDL, high Lp(a) and the presence of small, dense LDL may contribute to the incidence of coronary heart disease and that TC was not significantly associated with incidence of coronary heart disease in the Saudi population.

Keywords

Coronary disease, triglycerides, cholesterol, HDL, LDL, lipoproteins

Resumo

CONTEXTO: A população saudita é conhecida por apresentar dietas não saudáveis, além de inatividade física. OBJETIVO: Investigar os lipídeos como fatores de risco que podem associar-se com o aumento da incidência de doença cardíaca coronariana na população saudita, uma vez que isso foi encontrado na população ocidental. MATERIAIS E MÉTODOS: Duzentos e vinte indivíduos com suspeita de doença cardíaca coronariana submeteram-se a angiografia coronária e coleta de sangue, após jejum de 12 horas. Colesterol total e HDL, triglicerídeos, Lp(a) e lipase lipoproteica foram calculados por métodos padrão. LDL pequena e densa foi medida pelo método do iodixanol com ultracentrifugação por apenas 2,5 horas. RESULTADOS: Cento e quarenta indivíduos apresentaram resultado positivo para doença cardíaca coronariana, enquanto 80 pacientes mostraram resultado negativo. Os fatores de risco estatisticamente significantes para doença cardíaca coronariana na população saudita foram hipertrigliceridemia (1,93±0,95 versus 1,45±0,16 mmol/L; p<0,0001); baixo colesterol HDL (1,09±0,55 versus 1,33±0,63 mmol/L; p=0,0001); Lp(a) elevada (46,8±45,58 versus 29,06±17,03 mg/dL; p=0,019) e a presença de LDL pequena e densa (1,0314±0,0028 versus 1,0300±0,0003 g/kg; p=0,0099). Colesterol total (4,99±1,11 versus 4,75±1,11 mmol/L; p=0,099), colesterol LPL (35,56±26,6 versus 27,89±11,96 IU/L; p<0,059) e LDL (3,06±1,12 versus 2,79±1,08 mmol/L; p=0,08) não foram fatores de risco estatisticamente significantes para doença cardíaca coronariana. CONCLUSÕES: Este estudo indica que elevados triglicerídeos, baixo HDL, elevada Lp(a) e a presença de LDL pequena e densa podem contribuir para a incidência de doença cardíaca coronariana. O colesterol total não foi significantemente associado à incidência de doença cardíaca coronariana na população saudita.

Palavras-chave

Doença das coronárias, triglicerídeos, colesterol HDL, lipoproteínas LDL, lipoproteínas

Referências

Dawber TR, Meadors GF, Moore FEJ. Epidemiological approaches to heart disease: theFramingham Study. Am J Public Health.. 1951;41:279-86.

Anderson KM, Castelli WP, Levy DL. Cholesterol and mortality: 30 years follow up from theFramingham study. JAMA.. 1987;257:2176-80.

Assmann G, Schulte H, Cullen P. New and classical risk factors--the Münster heart study(PROCAM). Eur J Med Res.. 1997;2(6):237-42.

Mänttäri M, Elo o, Frick MH. The Helsinki Heart Study: basic design and randomizationprocedure. Eur Heart J.. 1987;8Suppl I:1-29.

Frick MH, OElo O, Haapa K. Helsinki Heart Study: primary-prevention trial withgemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors,and incidence of coronary heart disease. N Engl J Med.. 1987;317(20):1237-45.

Hokanson J, Austin M. Plasma triglyceride and coronary risk. A meta-analysis. Circulation.. 1993;88:523-33.

Miller M. Is hypertriglyceridaemia an independent risk factor for coronary heart disease?. Eur Heart J.. 1998;19Suppl H:H18-22.

Iso H, Naito Y, Sato S. Serum Triglycerides and Risk of Coronary Heart Disease among Japanese Men and Women. Am J Epidemiol.. 2001;153:490-9.

Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovasculardisease independent of high-density lipoprotein cholesterol level: a meta-analysis of population19based prospective studies. J Cardiovasc Risk.. 1996;3(2):213-9.

Ohashi R, Mu H, Wang X. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM.. 2005;98:845-56.

Tall AR, Costet P, Wang N. Regulation and mechanisms of macrophage cholesterol efflux. J Clin Invest.. 2002;110:899-904.

Austin MA, Breslow JL, Hennekens CH. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA.. 1988;260:1917-21.

Griffin BA, Freeman DJ, Tait GW. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis.. 1994;106:241-53.

Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA.. 1996;276:875-81.

Stampfer MJ, Krauss RM, Ma J. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA.. 1996;18;276(11):882-8.

Krauss RM. The tangled web of coronary risk factors. Am J Med.. 1991;90:36S-41S.

Krauss RM. Dense low density lipoproteins and coronary artery disease. Am J Cardiol.. 1995;75(6):53B-57B.

Krauss RM. Is the size of low-density lipoprotein particles related to the risk of coronary heart disease?. JAMA.. 2002;287:712-3.

Williams PT, Superko HR, Haskell WL. Smallest LDL particles are most strongly related to coronary disease progression in men. ArteriosclerThrombVasc Biol.. 2003;23:314-21.

Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. . 19;83(9B):25F-29F.

Haffner SM. Epidemiology of insulin resistance and its relation to coronary artery disease. Am J Cardiol.. 1999;84(1A):11J-14J.

Bernies KK, Krauss RM. 2002. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res.. 2002;43:1363-79.

La Belle M, Krauss RM. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J Lipid Res.. 1990;31:1577-88.

Al-Hazzaa HM. Physical activity, fitness and fatness among Saudi children and adolescents: implications for cardiovascular health. Saudi Med J.. 2002;23(2):144-5.

Davies IG, Graham JM, Griffin BA. Rapid Separation of LDL Subclasses byIodixanol Gradient Ultracentrifugation. Clin Chem.. 2003;49:1865-72.

Fielding BA, Frayn KN. Lipoprotein lipase and the disposition of fatty acids. Br J Nutr.. 1998;80:495-502.

Jukema JW, van Boven AJ, Groenemeijer B. The Asp9Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronaryatherosclerosis. Circulation.. 1996;94:1913-8.

Kastelein JJP, Jukema JW, Zwinderman AH. Lipoprotein lipase activity isassociated with the severity of angina pectoris. Circulation.. 2000;102:1629-33.

Guazzeli R, Fatini C, Piazzini M. Lipoprotein(a): genetic marker of precociousmyocardial infarction. Ann ital Med Int.. 1996;11:90-4.

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
5ddfba1a0e88255b5c61c40c jvb Articles
Links & Downloads
1677-7301 (Eletrônico)
J Vasc Bras ©2024 Todos os direitos reservados.

J Vasc Bras

Share this page
Page Sections